Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients
Launched by UNIVERSITY HOSPITAL, LIMOGES · Sep 19, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well patients who have had a stroke tolerate using virtual reality (VR) during robotic walking rehabilitation sessions. The main focus is to see if using VR helps these patients feel more comfortable and motivated compared to traditional rehabilitation methods. Researchers will also track how much walking patients can do in both VR and regular sessions.
To participate, individuals must be aged between 35 and 75, have had a stroke that has left them unable to walk without assistance, and be in the recovery phase of their condition (between 15 days and 6 months after the stroke). Participants should also be able to understand simple instructions. However, those with certain neurological or psychiatric conditions, serious heart or breathing problems, or other specific issues may not be eligible. If you join the study, you can expect to take part in engaging rehabilitation sessions using VR technology, which may make the experience more enjoyable and motivating.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hemiparesis following a first ischemic or hemorrhagic stroke;
- • subacute phase (15 days to 6 months);
- • Aged 35 to 75 years;
- • Non-walking subject (unable to walk 3 x 10 meters without human assistance or Functional Ambulation Classification ≤ 2);
- • Benefiting from robot-assisted walking rehabilitation in the readaptation and physical medecin department of the Limoges University Hospital;
- • Having the cognitive abilities to understand and follow simple verbal instructions (MMSE \< 24 or BDAE \< 2)
- • Be able to give informed consent to participate in this study.
- Exclusion Criteria:
- • Have neurological and psychiatric conditions, other than stroke;
- • Conditions contraindicating the use of virtual reality (e.g., epileptic disorders, major cerebellar syndrome).
- • Inability to evolve in a virtual environment (MSSQ-Short \> 26)
- • Patient with acute cardiovascular and respiratory disorders;
- • Patient who is subject to a legal protection measure or who is unable to give consent;
- • Person deprived of liberty
- • Person with high VR experience during the 5 years before stroke
- • pregnant woman, breastfeeding woman
About University Hospital, Limoges
The University Hospital of Limoges is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates patient care with cutting-edge research initiatives, fostering collaboration among healthcare professionals, researchers, and academic partners. With a commitment to improving patient outcomes and contributing to medical knowledge, the University Hospital of Limoges plays a pivotal role in translating scientific discoveries into effective therapeutic strategies. Its state-of-the-art facilities and expertise in various medical fields ensure rigorous trial management and adherence to ethical standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Limoges, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported